Side-by-side comparison of AI visibility scores, market position, and capabilities
Action camera company with $1.1B revenue; Hero series waterproof cameras for sports with GoPro Plus subscription amid smartphone camera competition compressing the addressable market.
GoPro is an action camera hardware company known for its durable, compact, mountable cameras used for capturing sports, adventure, and lifestyle content from first-person perspectives — the Hero camera series, 360-degree Max camera, and accessories ecosystem. Founded in 2002 by Nick Woodman in San Mateo, California and listed on NASDAQ, GoPro generates approximately $1.1 billion in annual revenue primarily from camera hardware sales, with a growing subscription business (GoPro Plus cloud storage and editing). The company has faced significant revenue pressure as smartphone cameras have improved, compressing the addressable market.\n\nGoPro's camera lineup (Hero 12, Hero 11 Black, Max 360) features waterproofing, shock resistance, and stabilization optimized for active use cases — surfing, skiing, mountain biking, motorsports, and aerial footage. The camera form factor supports mounting to helmets, boards, handlebars, and drones. GoPro's Quik mobile app provides AI-assisted video editing that automatically assembles highlight reels from raw footage. The GoPro Plus subscription provides cloud backup, camera replacement, and Quik premium editing features.\n\nIn 2025, GoPro faces continued challenges as the action camera market has contracted significantly from its peak — smartphone cameras now handle most casual action capture, and professional creators increasingly use mirrorless cameras with action-specific lenses. GoPro's strategy focuses on its core enthusiast customer (surfers, mountain bikers, motorsport participants) who value the waterproofing and mount ecosystem that smartphones cannot replicate, growing its subscription revenue for recurring income, and using the GoPro Labs hardware modification program to maintain credibility with technical creators. The 2025 strategy also includes cost reduction through workforce restructuring and manufacturing optimization.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.